Report cover image

Patient-Centric Clinical Trial Design & Digital Twin Technology

Publisher ResearchCubes
Published Mar 31, 2026
Length 40 Pages
SKU # RCUB21142020

Description

This benchmarking study examines how pharma leaders are decentralizing trials, using digital twins for protocol optimization, and embedding patient voices to improve recruitment and retention in underrepresented populations. The report addresses the diverse patient enrollment crisis, trial drop-out costs, FDA incentives for adaptive designs, and digital twin validation approaching mainstream adoption. Key findings include decentralized trials reducing recruitment timelines by 40%, digital twins optimizing protocols before in-vivo testing, and patient co-design improving retention by 30%. The report provides a roadmap for clinical operations leaders to implement patient-centric trial design, leverage digital twin technology, and build more inclusive, efficient clinical programs.

Table of Contents

40 Pages
EXECUTIVE SUMMARY
1.1 Methodology & Clinical Trial Landscape
1.2 The Enrollment Crisis: Diversity, Dropout & Cost Pressures
1.3 Key Findings: Decentralization, Digital Twins & Patient Co-Design
CLINICAL TRIAL MATURITY ASSESSMENT
2.1 Four Stages: From Central RCTs to Fully Decentralized, Patient-Centric Programs
2.2 Capability Assessment: Digital Infrastructure, Patient Engagement, Protocol Design
2.3 Technology Readiness: Digital Twins, Remote Monitoring, Data Integration
2.4 Peer Benchmarking (Clinical Trial Innovation Programs)
STRATEGIC IMPERATIVES FOR 2026
3.1 Patient-Centric Design: Co-Design & Voice Integration Into Protocols
3.2 Decentralized Trial Infrastructure: Telehealth, Remote Monitoring, At-Home Testing
3.3 Digital Twins: Protocol Optimization & Recruitment Prediction
3.4 Diversity & Inclusion: Reaching Underrepresented Populations
3.5 Adaptive Trial Designs: FDA Guidance & Implementation
PATIENT-CENTRIC TRIAL EXECUTION: BEST PRACTICES
4.1 Patient Advisory Boards & Participatory Design Processes
4.2 Remote Monitoring Technologies: Wearables, Connected Devices, Symptom Tracking
4.3 Telemedicine Integration & Site-Less Visit Options
4.4 Case Study: Roche Decentralized Trial Success
4.5 Case Study: Genentech Patient-Centric Protocol Design
DIGITAL TWIN TECHNOLOGY & PROTOCOL OPTIMIZATION
5.1 Digital Twin Concepts: In Silico Simulation & Optimization
5.2 Recruitment Prediction & Enrollment Forecasting
5.3 Dropout Risk Prediction & Early Intervention
5.4 FDA Guidance & Regulatory Acceptance
20-MONTH PATIENT-CENTRIC TRIAL IMPLEMENTATION
6.1 Phase 1 (Months 1-6): Patient Advisory Board & Protocol Co-Design
6.2 Phase 2 (Months 7-14): Decentralization & Technology Deployment
6.3 Phase 3 (Months 15-20): Digital Twin Validation & Scale
6.4 Budget, Team Structure & Risk Management
APPENDICES
A. Patient-Centric Trial Design Self-Assessment
B. Patient Advisory Board Toolkit & Engagement Strategies
C. Decentralization Technology Evaluation Matrix
D. Digital Twin Platform & Vendor Evaluation
E. FDA Compliance & Regulatory Guidance Checklist
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.